LNSR LENSAR, Inc.

LNSR financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1320350 Exchange: Nasdaq SIC: 3841 (Surgical & Medical Instruments & Apparatus) Latest filing: 10-Q filed Nov 10, 2026 Data checked: Nov 13, 2026
Showing 3 of 7 annual and 0 of 28 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$113.30M (Jun 2025)
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Incorporated
DE
Fiscal Year End
December (1231)
Phone
888-536-7271
EIN
320125724
Headquarters
ORLANDO, FL, 32826
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: LensAR Inc (2007–2015) · LaserSoft Vision Inc (2005–2006)

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$60.08M
Net Income
$33.69M
Total Assets
$67.07M
Total Equity
$11.07M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
52%
Operating Margin
-3.3%
Net Margin
56.1%
Return on Equity
304.4%
Return on Assets
50.2%
Current Ratio
2.25x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for LENSAR, Inc. combined $58.44M of revenue with net loss of $34.28M and an operating cash outflow of $14.83M. Revenue of $58.44M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 9.2% above fiscal 2024 revenue of $53.49M, marking a year-over-year increase. Diluted earnings per share were -$2.87, translating the period’s attributable earnings into the amount reported for each diluted share. The company employed $71.43M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 0.82x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $27.12M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross margin was 46.4%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $24.58M after the reported operating expense base. An operating margin of -42.1% reflected costs exceeding revenue-level gross profit by 42.1% of sales. The company ended the period with a net loss of $34.28M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 58.7% after all recognized items. The company reported negative EBITDA of $21.00M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The company reported a pretax loss of $34.28M, before the effect of income taxes. The pretax loss equaled 58.7% of revenue, measuring the pre-tax deficit against sales. The loss-to-assets relationship was 48.0%, placing the bottom-line deficit against the company’s resource base. Compared with a $31.40M net loss in fiscal 2024, the current loss increased to $34.28M.

Liquidity and Capital Structure

At period end, the $71.43M asset base was financed through $83.67M of liabilities and -$26.02M of equity. The company reported negative equity of -$26.02M, a capital deficit that reduces its ability to absorb losses through book equity. At period end, current assets of $46.77M compared with current liabilities of $40.57M, defining the company’s short-term resource position. At 1.15x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $12.97M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 32.0% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented -36.4% of total assets, quantifying the balance-sheet share supported by shareholder capital. Relative to total assets, liabilities measured 117.1%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 18.2%, comparing reported cash and equivalents with the full positive asset balance. Compared with $66.30M in fiscal 2024, the current asset base moved 7.7% and finished higher. Book equity was 635.2% lower than fiscal 2024 equity of $4.86M, showing how shareholder capital changed year over year. Cash and equivalents were 20.2% lower than fiscal 2024 cash of $16.26M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $14.83M, showing that operations absorbed cash during the period. The company spent $83.00K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. The company recorded a $14.91M cash deficit after capital spending for the period. Free-cash-flow margin was -25.5%, reflecting a cash deficit equal to 25.5% of revenue after capital spending. Relative to total assets, the post-investment cash deficit measured 20.9%.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for LENSAR, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $58.44M $53.49M $42.16M
Cost of Revenue $31.31M $27.64M $21.06M
Gross Profit $27.12M $25.85M $21.11M
OPERATING EXPENSES
R&D Expense $5.62M $5.33M $6.14M
SG&A Expense $45.16M $26.49M $26.10M
Other Operating Expenses (derived) $921.00K $4.70M $1.10M
Operating Income $-24.58M $-10.67M $-12.23M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $636.00K $660.00K $698.00K
Pretax Income $-34.28M $-31.40M $-14.38M
Net Income $-34.28M $-31.40M $-14.38M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-2.87 $-2.73 $-1.31
Diluted Shares 11.96M 11.52M 10.97M
EBITDA $-21.00M $-7.70M $-9.81M
Depreciation & Amortization $3.58M $2.96M $2.42M
Balance Sheet
ASSETS
Cash & Equivalents $12.97M $16.26M $20.62M
Short-term Investments $5.00M $6.19M $3.44M
Accounts Receivable $6.38M $6.09M $4.00M
Inventory $21.52M $11.43M $15.69M
Other Current Assets $601.00K $1.62M $2.37M
Current Assets $46.77M $41.98M $46.44M
PP&E (Net) $505.00K $664.00K $679.00K
Intangible Assets $5.19M $6.11M $11.03M
Other Noncurrent Assets $2.75M $2.62M $2.21M
Noncurrent Assets $24.66M $24.32M $23.14M
Total Assets $71.43M $66.30M $69.59M
LIABILITIES
Accounts Payable $18.98M $6.00M $4.01M
Other Current Liabilities $583.00K $597.00K $1.00M
Current Liabilities $40.57M $15.00M $11.63M
Other Noncurrent Liabilities $909.00K $702.00K $570.00K
Noncurrent Liabilities $43.09M $32.65M $10.78M
Total Liabilities $83.67M $47.65M $22.41M
EQUITY
Common Stock $120.00K $116.00K $113.00K
Additional Paid-in Capital $151.43M $148.04M $145.20M
Retained Earnings $-177.58M $-143.30M $-111.89M
Accumulated OCI $4.00K $6.00K $4.00K
Total Equity $-26.02M $4.86M $33.43M
Temporary Equity $13.78M $13.78M $13.75M
Total Liabilities & Equity $71.43M $66.30M $69.59M
SUPPLEMENTAL
Shares Outstanding 11.99M 11.65M 11.33M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-14.83M $-2.28M $-9.66M
Capital Expenditures $83.00K $156.00K $236.00K
Cash from Investing $1.28M $-2.16M $-4.16M
Cash from Financing $10.26M $78.00K $19.76M
Free Cash Flow $-14.91M $-2.43M $-9.90M
Beginning Cash (CFS) $16.26M $20.62M $14.67M
Net Change in Cash $-3.29M $-4.36M $5.95M
Effect of FX on Cash - - -
Calculated Ending Cash $12.97M $16.26M $20.62M
Cash per BS $12.97M $16.26M $20.62M
Cash scope difference (CFS − BS) - - -
Cash per CFS $12.97M $16.26M $20.62M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is LENSAR, Inc.'s annual revenue?

LENSAR, Inc. reported $60.08M in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is LENSAR, Inc. profitable?

Yes. LENSAR, Inc. reported $33.69M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.